0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A taxonomy of early diagnosis research to guide study design and funding prioritisation

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Researchers and research funders aiming to improve diagnosis seek to identify if, when, where, and how earlier diagnosis is possible. This has led to the propagation of research studies using a wide range of methodologies and data sources to explore diagnostic processes. Many such studies use electronic health record data and focus on cancer diagnosis. Based on this literature, we propose a taxonomy to guide the design and support the synthesis of early diagnosis research, focusing on five key questions:

          • Do healthcare use patterns suggest earlier diagnosis could be possible?

          • How does the diagnostic process begin?

          • How do patients progress from presentation to diagnosis?

          • How long does the diagnostic process take?

          • Could anything have been done differently to reach the correct diagnosis sooner?

          We define families of diagnostic research study designs addressing each of these questions and appraise their unique or complementary contributions and limitations. We identify three further questions on relationships between the families and their relevance for examining patient group inequalities, supported with examples from the cancer literature. Although exemplified through cancer as a disease model, we recognise the framework is also applicable to non-neoplastic disease. The proposed framework can guide future study design and research funding prioritisation.

          Related collections

          Most cited references63

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review

          Background: It is unclear whether more timely cancer diagnosis brings favourable outcomes, with much of the previous evidence, in some cancers, being equivocal. We set out to determine whether there is an association between time to diagnosis, treatment and clinical outcomes, across all cancers for symptomatic presentations. Methods: Systematic review of the literature and narrative synthesis. Results: We included 177 articles reporting 209 studies. These studies varied in study design, the time intervals assessed and the outcomes reported. Study quality was variable, with a small number of higher-quality studies. Heterogeneity precluded definitive findings. The cancers with more reports of an association between shorter times to diagnosis and more favourable outcomes were breast, colorectal, head and neck, testicular and melanoma. Conclusions: This is the first review encompassing many cancer types, and we have demonstrated those cancers in which more evidence of an association between shorter times to diagnosis and more favourable outcomes exists, and where it is lacking. We believe that it is reasonable to assume that efforts to expedite the diagnosis of symptomatic cancer are likely to have benefits for patients in terms of improved survival, earlier-stage diagnosis and improved quality of life, although these benefits vary between cancers.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Aarhus statement: improving design and reporting of studies on early cancer diagnosis

            Early diagnosis is a key factor in improving the outcomes of cancer patients. A greater understanding of the pre-diagnostic patient pathways is vital yet, at present, research in this field lacks consistent definitions and methods. As a consequence much early diagnosis research is difficult to interpret. A consensus group was formed with the aim of producing guidance and a checklist for early cancer-diagnosis researchers. A consensus conference approach combined with nominal group techniques was used. The work was supported by a systematic review of early diagnosis literature, focussing on existing instruments used to measure time points and intervals in early cancer-diagnosis research. A series of recommendations for definitions and methodological approaches is presented. This is complemented by a checklist that early diagnosis researchers can use when designing and conducting studies in this field. The Aarhus checklist is a resource for early cancer-diagnosis research that should promote greater precision and transparency in both definitions and methods. Further work will examine whether the checklist can be readily adopted by researchers, and feedback on the guidance will be used in future updates.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets

              Background: Cancer survival in England is lower than the European average, which has been at least partly attributed to later stage at diagnosis in English patients. There are substantial regional and demographic variations in cancer survival across England. The majority of patients are diagnosed following symptomatic or incidental presentation. This study defines a methodology by which the route the patient follows to the point of diagnosis can be categorised to examine demographic, organisational, service and personal reasons for delayed diagnosis. Methods: Administrative Hospital Episode Statistics data are linked with Cancer Waiting Times data, data from the cancer screening programmes and cancer registration data. Using these data sets, every case of cancer registered in England, which was diagnosed in 2006–2008, is categorised into one of eight ‘Routes to Diagnosis'. Results: Different cancer types show substantial differences between the proportion of cases that present by each route, in reasonable agreement with previous clinical studies. Patients presenting via Emergency routes have substantially lower 1-year relative survival. Conclusion: Linked cancer registration and administrative data can be used to robustly categorise the route to a cancer diagnosis for all patients. These categories can be used to enhance understanding of and explore possible reasons for delayed diagnosis.
                Bookmark

                Author and article information

                Contributors
                emma.whitfield.20@ucl.ac.uk
                Journal
                Br J Cancer
                Br J Cancer
                British Journal of Cancer
                Nature Publishing Group UK (London )
                0007-0920
                1532-1827
                4 October 2023
                4 October 2023
                9 November 2023
                : 129
                : 10
                : 1527-1534
                Affiliations
                [1 ]ECHO (Epidemiology of Cancer Healthcare & Outcomes), Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, UCL (University College London), ( https://ror.org/02jx3x895) 1-19 Torrington Place, London, WC1E 7HB UK
                [2 ]GRID grid.83440.3b, ISNI 0000000121901201, Institute of Health Informatics, , UCL, ; London, UK
                [3 ]GRID grid.452924.c, ISNI 0000 0001 0540 7035, British Heart Foundation Data Science Centre, ; London, UK
                [4 ]Health Data Research UK, ( https://ror.org/04rtjaj74) London, UK
                [5 ]GRID grid.83440.3b, ISNI 0000000121901201, UCL Hospitals Biomedical Research Centre, ; London, UK
                [6 ]Faculty of Medicine, University Vita-Salute San Raffaele, ( https://ror.org/01gmqr298) Milan, Italy
                Author information
                http://orcid.org/0000-0001-5427-7150
                http://orcid.org/0000-0002-0643-7890
                http://orcid.org/0000-0003-3845-9493
                http://orcid.org/0000-0002-2873-7421
                Article
                2450
                10.1038/s41416-023-02450-4
                10645731
                37794179
                971a86c4-3ffe-4fd8-a4ca-9c17c2e95f90
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 31 March 2023
                : 12 September 2023
                : 20 September 2023
                Funding
                Funded by: FundRef https://doi.org/10.13039/100004440, Wellcome Trust (Wellcome);
                Award ID: 218529/Z/19/Z
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100000289, Cancer Research UK (CRUK);
                Award ID: C18081/A18180
                Award ID: C18081/A18180
                Award ID: EDDAPA-2022/100002
                Award ID: C18081/A18180
                Award ID: C18081/A18180
                Award Recipient :
                Categories
                Perspective
                Custom metadata
                © Springer Nature Limited 2023

                Oncology & Radiotherapy
                diagnosis,cancer epidemiology
                Oncology & Radiotherapy
                diagnosis, cancer epidemiology

                Comments

                Comment on this article